Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Mckesson Corp (MCK)

Mckesson Corp (MCK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mckesson Corp 6555 STATE HIGHWAY 161 IRVING TX 75039 USA

www.mckesson.com Employees: 51,000 P: 972-446-4800

Sector:

Medical

Description:

McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.

Key Statistics

Overview:

Market Capitalization, $K 82,119,856
Enterprise Value, $K 89,278,856
Shares Outstanding, K 125,326
Annual Sales, $ 308,951 M
Annual Net Income, $ 3,002 M
Last Quarter Sales, $ 95,294 M
Last Quarter Net Income, $ 879,000 K
EBIT, $ 4,047 M
EBITDA, $ 4,682 M
60-Month Beta 0.51
% of Insider Shareholders 0.11%
% of Institutional Shareholders 85.07%
Float, K 125,188
% Float 99.89%
Short Volume Ratio 0.44

Growth:

1-Year Return 24.90%
3-Year Return 113.09%
5-Year Return 426.34%
5-Year Revenue Growth 44.15%
5-Year Earnings Growth 102.21%
5-Year Dividend Growth 58.94%

Per-Share Information:

Most Recent Earnings 8.03 on 02/05/25
Next Earnings Date 05/06/25
Earnings Per Share ttm 29.16
EPS Growth vs. Prev Qtr 13.58%
EPS Growth vs. Prev Year 3.75%
Annual Dividend Rate, $ 2.75
Annual Dividend Yield 0.42%
Most Recent Dividend 0.710 on 03/03/25
Next Ex-Dividends Date 03/03/25
Dividend Payable Date 04/01/25
Dividend Payout Ratio 9.07%
Most Recent Split 2-1 on 01/05/98

MCK Ratios

Ratio
Price/Earnings ttm 22.31
Price/Earnings forward 19.85
Price/Earnings to Growth 1.39
Return-on-Equity % -181.26%
Return-on-Assets % 5.34%
Profit Margin % 0.97%
Debt/Equity -5.04
Price/Sales 0.26
Price/Cash Flow 19.81
Price/Book N/A
Book Value/Share -21.30
Interest Coverage 16.04

MCK Dividends

Date Value
03/03/25 $0.7100
12/02/24 $0.7100
08/30/24 $0.7100
06/03/24 $0.6200
05/31/24 $0.6200
02/29/24 $0.6200
11/30/23 $0.6200
08/31/23 $0.6200
05/31/23 $0.5400
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar